We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Baoji Pharmaceutical Stock

Invest in or calculate the value of your shares in Baoji Pharmaceutical or other pre-IPO companies through EquityZen's platform.

Get Started

Baoji Pharmaceutical Stock (BAPH)

Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production.

About Baoji Pharmaceutical Stock

Founded

2019

Industries

Science and Engineering, Health Care, Biotechnology

Baoji Pharmaceutical is a biopharma R&D manufacturer and a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. Baoji Pharmaceutical has established "recombinant human hyaluronidase-based subcutaneous drug delivery technology" and "pharmaceutical equipment required by assisted reproductive" as the core of its two key research and development directions. The company has established three core technology platforms, including a "medicinal enzyme engineering technology center," a "glycoprotein drug engineering technology center," and an "antibody targeting enzyme engineering technology center."
Locked Features

Join now and verify your accreditation status to gain access to:

  • Baoji Pharmaceutical Current Valuation
  • Baoji Pharmaceutical Stock Price
  • Baoji Pharmaceutical Management
  • Available deals in Baoji Pharmaceutical and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Baoji Pharmaceutical Cap Table and Funding History by Share Class and Liquidity Preferences
    • Baoji Pharmaceutical Revenue and Financials
    • Baoji Pharmaceutical Highlights
    • Baoji Pharmaceutical Business Model
    • Baoji Pharmaceutical Risk Factors
  • Baoji Pharmaceutical Research Report from SACRA Research
Join Now

Trading Baoji Pharmaceutical Stock

How to invest in Baoji Pharmaceutical stock?

Accredited investors can buy pre-IPO stock in companies like Baoji Pharmaceutical through EquityZen funds. These investments are made available by existing Baoji Pharmaceutical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Baoji Pharmaceutical stock?

Shareholders can sell their Baoji Pharmaceutical stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."